Kailera Therapeutics, Inc. (KLRA)
NMS · Healthcare · Biotechnology
$13.27
+2.71%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.72B
Shares Outstanding
129.6M
Exchange
NMS
Currency
USD
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (20.5M) | (30.7M) | (84.7M) | (121.4M) |
| Net Income | (18.0M) | (28.9M) | (78.9M) | (111.3M) |
| Diluted EPS | $-0.15 | $-0.25 | $-0.67 | $-1.09 |
Annual Financials
| Metric | 2025-12-31 |
|---|---|
| Revenue | 0.00 |
| Operating Income | (158.3M) |
| Net Income | (149.0M) |
| Diluted EPS | $-1.26 |